Cerner Corporation (NASDAQ:CERN) has a beta of 0.72, a 12-month trailing P/E ratio of 28.62, and a growth ratio of 2.49. The stock’s Relative Strength Index (RSI) is 49.55, with weekly volatility at 1.62% and ATR at 1.23. The CERN stock’s 52-week price range has touched low of $63.11 and a $84.20 high. Its shares traded higher over the last trading session, gaining 0.10% on 04/07/21. The shares fell to a low of $72.05 before closing at $72.26. Intraday shares traded counted 1.65 million, which was 32.17% higher than its 30-day average trading volume of 2.44M. CERN’s previous close was $72.19 while the outstanding shares total 306.40M.
Investors have identified the Health Information Services company Cerner Corporation as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $21.82 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Cerner Corporation (CERN) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 2.65 billion total, with 1.17 billion as their total liabilities.
Having a look at the company’s valuation, the company is expected to record 3.09 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on CERN sounds very interesting.
Is the stock of CERN attractive?
In related news, Exec. VP & CFO, Erceg Mark J bought 3,520 shares of the company’s stock in a transaction that recorded on Mar 10. The purchase was performed at an average price of 71.06, for a total value of 250,131. As the purchase deal closes, the Exec. VP & CFO, Erceg Mark J now bought 3,506 shares of the company’s stock, valued at 249,943. Also, Exec. VP & CFO, Erceg Mark J bought 3,521 shares of the company’s stock in a deal that was recorded on Mar 08. The shares were cost at an average price of 71.05 per share, with a total market value of 250,167. Following this completion of disposal, the Exec. VP & CFO, Erceg Mark J now holds 3,639 shares of the company’s stock, valued at 249,490. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.15%.
11 out of 22 analysts covering the stock have rated it a Buy, while 8 have maintained a Hold recommendation on Cerner Corporation. 1 analysts has assigned a Sell rating on the CERN stock. The 12-month mean consensus price target for the company’s shares has been set at $82.00.